Top Stories (2026) -
(1701 items)
Subscribe to RSS
(All links open in new tab)
| Oct 15, 2026 |
Marijuana Is A Popular Tool For People Trying To Quit Smoking Cigarettes, Rivaling Prescription Nicotine Cessation Medications, Study Shows Almost as many people are using marijuana to help them quit smoking cigarettes as are using prescription nicotine cessation aids, according to a new study conducted by officials with the U.S. Department of Veterans Affairs (VA) and other institutions. The research, however, raises questions about potential side effects experienced by people who are using cannabis to quit tobacco products. |
|---|---|
| Oct 15, 2026 |
Nearly one-third of cannabis consumers say they have completely cut out alcohol
Nearly one-third of cannabis consumers say they have completely replaced alcohol with cannabis, while almost two-thirds report drinking less as a result of their cannabis use, according to a new survey conducted in the United States. The poll was conducted as part of Sober October, an annual initiative encouraging people to abstain from alcohol for a month, by medical cannabis telehealth company NuggMD. Over 1000 cannabis consumers were polled between 24 and 26 September 2026. |
| Oct 15, 2026 |
Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabis company, today announced that it has completed its previously announced acquisition of CanAdelaar B.V. ("CanAdelaar"), the largest cannabis company operating within the Netherlands' adult-use cannabis pilot program, the Wietexperiment. |
| Oct 15, 2026 |
Irradiated Medical Cannabis and the Science Behind the Debate
Much of the discussion involving irradiated medical cannabis centres on whether the treatment affects THC or terpenes. Those are reasonable questions, but I think the microbiology deserves an equal share of the attention. Irradiation can substantially reduce the number of viable microorganisms in flower, but any mould that has already grown remains physically present after treatment. |
| Oct 15, 2026 |
Cannabis doesn’t make you violent – despite what recent reports have claimed
n what looked like a return to the dark days of Reefer Madness – a 1936 film that portrayed cannabis as a drug that could drive people to madness and murder – a recent article in the Daily Telegraph claimed that cannabis users are “twice as likely to be violent”. The claim comes from a systematic review by King’s College London that combined 63 studies covering more than 265,000 people. The researchers did, indeed, find a link between cannabis use and violence, but the headline overstates what the numbers can tell us. There are three reasons to be cautious: other factors that could explain the link (known as confounders), the way the studies were designed, and potential biases in how the data was gathered. |
| Oct 14, 2026 |
Tilray Medical Facility in Portugal Gains Approval for In-House Testing
Portugal’s National Authority of Medicines and Health Products has approved the quality control laboratory at Tilray Medical’s EU-GMP-certified facility in Cantanhede, Portugal, to conduct microbiological and chemical/physical testing in-house. The company says the INFARMED approval gives Tilray Medical greater control over critical quality testing, accelerates product release capabilities, and strengthens its Portugal facility as a strategic launchpad for medical cannabis supply across regulated international markets. |
| Oct 14, 2026 |
New cannabis packaging business launches in Canada
CropPak has launched a new cannabis packaging company and website created specifically for cannabis growers and brands. The launch marks the start of operations for the Abbotsford-based business, which was established around a factory-direct packaging model intended to help cultivators manage packaging expenses as tighter operating margins increase the importance of cost control. |
| Oct 14, 2026 |
Herbal Dispatch Ships 3,000 Units of 2026 Happy Hour Holiday Cannabis Calendar to BCLDB Following Sold-Out 2025 Edition Herbal Dispatch (LUFFF) sold and shipped 3,000 units of its 2026 Happy Hour Holiday Cannabis Calendar to the British Columbia Liquor Distribution Branch. The shipment represents over $100,000 in wholesale sales at $34.99 per unit, with an approximate gross margin of 42%. Produced with Coast Mountain Cannabis, the Calendar will reach BC Cannabis Stores and private licensed retailers. Production increased to 4,200 units, about 25% above the sold-out 2025 run of 3,350 units. |
| Oct 14, 2026 |
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside EDMONTON, AB, Oct. 14, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on the unanimous recommendation of a special committee of independent directors (the "Special Committee"), unanimously recommends that shareholders REJECT the hostile offer by Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) for all of the issued and outstanding common shares of the Company, as revised in the Notice of Variation, Change and Extension filed by Curaleaf on October 6, 2026 (the "Hostile Bid"). "Curaleaf's revised offer still does not reflect the value of the company Aurora shareholders own today. Aurora is debt-free with a strong cash position, and we believe the revised Hostile Bid continues to ask shareholders to give up that strength, and their future upside, at a discount," said Miguel Martin, Executive Chairman and CEO of Aurora. |
| Oct 14, 2026 |
German Organizations Criticize Changes To Cannabis Flower Reimbursements This month, the Health Committee of the German Bundestag held a hearing to discuss the coalition’s proposed amendments to the Statutory Health Insurance (SHI) Contribution Rate Stabilization Act. The measure was approved before the Bundestag’s summer recess. The German Hemp Association (DHV) issued a statement leading up to the recent Health Committee hearing. |
| Oct 14, 2026 |
The Aurora Ménage à Trois: Three Shifts in Seven Days
Curaleaf Holdings’ battle to acquire Aurora Cannabis has shifted in favour of the Canadian producer on multiple fronts over the last week. Not only has Curaleaf raised its hostile bid by 25% to an implied US$5.00 per share, but media reports suggest the BAT-backed (British American Tobacco) Organigram Global is now also in contention to merge with Aurora. Alongside the completion of a major expansion of its German EU-GMP facility expected to double its annual flower production, Aurora is now in a considerably stronger position than just a week earlier. |
| Oct 14, 2026 |
Cannabis prices down $1 to date in 2026 Cannabis prices hit a new low in September, falling to an average $6.57 per gram. Total sales in both the adult-use and medical markets also fell between August and September. The average price per gram of marijuana has fallen by just over a dollar in 2026. In January, marijuana averaged $7.63 a gram. Prices have generally fallen each month, except between April and May where the price per gram increased by nine cents. Marijuana prices peaked in March 2024, at an average $12.51 per gram and have largely fallen month-over-month since. The average price per adult-use product has also followed the same trend. In September, the average adult-use product cost $27.24, down from $28.09 the previous month. |
| Oct 14, 2026 |
Why Aurora Cannabis (TSX:ACB) Is Defending Its Medical Cannabis Strategy Against Curaleaf's Revised Bid Aurora Cannabis Inc. (TSX:ACB) is in the spotlight because it is defending against a hostile take-over bid from Curaleaf Holdings, Inc., which was revised in early October to an offer that Curaleaf values at US$5.00 per Aurora share. Aurora's board had said it would give a formal recommendation on the revised terms after its special committee reviews them. In the meantime it has told shareholders to take no action. The company's case for independence rests on a debt-free balance sheet, a growing international medical cannabis business and EU-GMP certified production capacity. |
| Oct 13, 2026 |
Puerto Rico Rolls Back Workplace Protections for Medical Cannabis Patients. Who’s Left Out? Puerto Rico’s new Act 204-2026 creates an exception to workplace protections for registered medical cannabis patients in certain safety-sensitive transportation roles. The law does not eliminate the medical cannabis program or protections for patients generally, but it gives employers a new legal basis for employment decisions involving covered workers. |
| Oct 13, 2026 |
Clinical Trials Begin in U.S. for First Cannabis-Based Medicine for Chronic Pain The first clinical trials in the United States for a cannabis-based medicine for chronic pain are getting underway. New York State has authorized a clinical trial of VER-01 in patients with chronic low back pain from lumbosacral radiculopathy, commonly known as sciatica. VER-01 was developed by Vertanical, a German biopharmaceutical company, and recently became available by prescription in Europe, where it is sold under the brand name Exilby. Exilby is a full spectrum extract derived from THC, CBD and terpenes found in cannabis sativa. Unlike other cannabis-based medicines already on the market, such as Epidolex and Marinol, which are used to treat epilepsy and improve appetite, Exilby was specifically developed to treat chronic pain. |
| Oct 13, 2026 |
Canadian cannabis company Organigram enters fight for Aurora
The fight to acquire Aurora Cannabis may include a global tobacco giant. In a signal that Curaleaf Holdings’ hostile takeover bid could be undercut, Organigram Holdings, a Canadian licensed producer partly owned by British American Tobacco, is also interested in acquiring Aurora, cannabis newsletter Cultivated reported. |
| Oct 13, 2026 |
How Many U.S. Adults Consume Cannabis?
A team of researchers affiliated with the U.S. National Institutes of Health recently conducted a study examining, among other things, the rate of cannabis use by adults in the United States. The study’s findings were published in the journal Addictive Behaviors. The study used data from the 2024 Health Information National Trends Survey, which asked about past 12-month cannabis use. The survey also asked about which consumption method cannabis consumers used, such as smoking, vaping, dabbing, edibles, drinkables, and topicals. The study also asked about tobacco use. “An estimated 23.1% of US adults reported past 12-month cannabis use: 62.6% smoked, 57.6% consumed, 40.1% vaped, 15.2% applied lotion, and 12.4% dabbed, with over half (52.7%) endorsing >1 route of administration.” the study found. |
| Oct 13, 2026 |
U.S. Legal Marijuana Sales Reach $2.52 Billion in September, Bringing 2026 Total to $21.6 Billion
Legal marijuana sales across the United States reached approximately $2.52 billion in September, bringing the estimated total for the first nine months of 2026 to $21.6 billion, according to an analysis by The Marijuana Herald. The September estimate was approximately 1.1% below the $2.55 billion reported for August, although daily sales were slightly higher at $84 million compared to $82 million. September’s sales were also around 8% higher than the $2.34 billion sold in September, 2025. The roughly $2.52 billion in sales brings 2026’s year-to-date total to $21.6 billion. |
| Oct 13, 2026 |
Cannabis Stocks in 2026: What Is Listed, What Is Next and How the Market Trades
On April 22, 2026, US Acting Attorney General Todd Blanche signed an order moving cannabis under a state medical licence and any FDA-approved cannabis drugs to Schedule III, formally recognising its medical value and unlocking DEA registration for commercial operators for the first time. While medical cannabis remained in Schedule I of the Controlled Substances Act (CSA), a company whose primary business is growing and selling cannabis could not accurately state that it complied with federal law and thus couldn’t meet the listing requirements for both NYSE and NASDAQ. As such, until this change, cannabis operators have been effectively locked out of major US exchanges due to the federal illegality of cannabis. For the first time in the industry’s history, US cannabis operators had a path to list their stocks on blue-chip exchanges. |
| Oct 13, 2026 |
Colorado’s Weed Regulator Can Afford 84 of Its 158 Staffers: Four States on What Legalization Left Unfinished.
Colorado’s cannabis regulator is authorized for roughly 158 staff positions. It has about 84 employees. The Marijuana Enforcement Division relies heavily on the application and licensing fees it collects from the industry it oversees, and as the state’s market has slowed, so has the money. Raising fees to close the gap, says Dominique D. Mendiola, the division’s senior director, “risks adding pressure to businesses already navigating a declining market.” It is the kind of problem nobody campaigned on. Legalization was sold as a finish line. More than a decade after the first adult-use sales, the governments running these markets describe it as the start of a job that keeps changing: fixing early decisions, catching up on equity, funding regulators and now bracing for whatever Washington does next. |
| Oct 13, 2026 |
Anti-Marijuana Attitudes In Sports Are Easing Up, But Ongoing Stigma Makes Athletic Trainers’ Jobs Harder, NFL-Funded Study Shows Long-held anti-marijuana attitudes in sports leagues are “evolving” as social trends are “driving more openness to cannabis” as an alternative to opioids for treating athletes’ pain—but ongoing stigma creates trust issues that makes it harder for medical staff to do their jobs, according to a new study funded by the National Football League (NFL). “Negative perceptions and longstanding stigma continue to shape how cannabis use is viewed among athletes, medical staff, and society, making open discussion difficult,” the study, published this week in the journal Sports Health, said. However, “medical professionals, particularly younger or research-focused staff, are increasingly seeing cannabis as a safer or more effective option than alcohol, opioids, or other prescription drugs.” |
| Oct 12, 2026 |
Cannabis Telemedicine in Germany: Navigating the Legal Landscape
Key Points Remote medical cannabis treatment in Germany must meet medical safeguards, and advertising is subject to separate restrictions. EU cross-border telemedicine creates opportunities while leaving important questions about advertising and professional standards unresolved. Proposed changes to the Medical Cannabis Act would require in-person consultations for cannabis flowers and restrict mail-order dispensing; the amendments remain unadopted. |
| Oct 12, 2026 |
Cannabis Policy Again Overlooked in Fall Elections Despite Economic Impact
As provincial and municipal elections unfold across Canada this fall, cannabis policy remains largely sidelined by broader political issues, even as the legal sector drives significant economic activity. Some provincial and municipal elections have touched on cannabis issues, but for the most part, cannabis continues to take a back seat to issues like the economy, crime, and housing. In British Columbia, the cannabis industry faces a snap election with no major party platforms addressing its concerns, though advocacy groups are pushing for economic reforms and retail regulations. In Quebec, a CAQ defeat could mean future changes to the province’s strict regulations, but that remains to be seen. In Manitoba, communities are split over local plebiscites on cannabis retail, and Ontario towns like Aurora grapple with local implementation challenges, retail task forces, and public safety debates. |
| Oct 12, 2026 |
Uganda Launches a Cooperative Dedicated to Medical Cannabis Uganda continues to structuring its medical cannabis industry with the launch of a national cooperative bringing together producers, investors, and stakeholders in the medical cannabis and hemp industries. Chaired by the minister Justine Kasule Lumumba, this new organization aims to support the sector’s development, facilitate access to markets and investments, while ensuring compliance with a strict regulatory framework. |
| Oct 12, 2026 |
Veterans call on government to reimburse medical cannabis costs
Armed forces veterans are calling on the UK government to reimburse the cost of prescribed medical cannabis, with a new parliamentary petition seeking support similar to that available in Canada and Australia. The campaign, launched by Wellford Clinics in partnership with veterans, comes alongside a Veterans Access Scheme that offers free lifetime appointments and waives prescription fees for eligible former service personnel. The clinic says the scheme could save patients up to £240 a year. |
| Oct 12, 2026 |
Medical Marijuana Improves Cancer-Related Symptoms And Helps Reduce Use Of Opioids, Federally Funded Study Shows A new federally funded study shows that “most cannabis users reported that it improved their cancer-related symptoms”—including pain, appetite, mood and insomnia—while also serving as a substitute for opioids for nearly a third of them. Researchers with the Pennsylvania State University College of Medicine, Penn State Cancer Institute and Fox Chase Cancer Center surveyed 186 patients, about a quarter of whom (26 percent) had used cannabis since their diagnosis. |
| Oct 12, 2026 |
Overseed: France's First Medical Cannabis Biotech Company
Overseed is one of the startups aiming to make France a producer of medical cannabis—rather than just a market supplied by imports from Canada or the Netherlands. Founded in Orléans in 2021 by Hugues Péribère, one of the first biotech companies approved by the ANSM for R&D in pharmaceutical cannabis production, the company is patiently building the value chain that would one day enable France to have its own domestically produced 100% cannabis-based medications. |
| Oct 12, 2026 |
California Cannabis Dispensary Launch First RFID-Powered Technology Perfect Union Northside dispensary in Sacramento has become the first licensed cannabis retailer in California approved by the California Department of Cannabis Control (DCC) to launch RFID-powered self-checkout technology through EXO, marking a significant milestone in the evolution of cannabis retail. Following a successful observation and review by state regulators, Perfect Union Northside received confirmation that the EXO self-checkout system could remain on the sales floor and continue operating while maintaining compliance with California cannabis regulations. |
| Oct 10, 2026 |
Pipedream? Africa’s cannabis licensing push outpaces evidence of commercial returns Africa’s regulated cannabis industries are expanding through cultivation projects and processing investments, but growth in licences and production has yet to be matched by clear evidence of sales revenue, export earnings or profitability. The emerging businesses fall into distinct markets: industrial hemp, medicinal and pharmaceutical cannabis, and regulated cannabis-derived consumer products such as cosmetics and food supplements. Recreational cannabis is a separate category, governed by different rules on possession, cultivation and sales. Each market has its own customers, regulatory requirements and commercial prospects. |
| Oct 10, 2026 |
Curaleaf 'Outraged' by Reported Competing Offer for Aurora Cannabis
Curaleaf may be facing some competition as it pursues a hostile takeover bid for Aurora Cannabis. According to Cultivated, Organigram Global, a Canada-based cannabis operator, has been in talks with Aurora for the past few weeks regarding a potential merger. Neither company would confirm the discussions, but Curaleaf has already blasted the idea of the two companies pursuing any type of M&A. |
| Oct 10, 2026 |
Top Cannabis Stocks To Add to Your Watchlist - October 10th
Tilray Brands, Trulieve Cannabis, Glass House Brands, Aurora Cannabis, Canopy Growth, Cronos Group, and High Tide are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the cultivation, production, distribution, retail, or ancillary services related to cannabis and cannabis-derived products. For stock market investors, they represent an opportunity to gain exposure to the cannabis industry but may carry heightened risks due to regulatory uncertainty, changing laws, market volatility, and evolving consumer demand. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days. |
| Oct 10, 2026 |
Trump Complains That Democratic-Run Cities Smell Like Marijuana President Donald Trump has a number of complaints about cities run by Democrats—including that they smell like marijuana. During a Friday speech commemorating Columbus Day, the president criticized the “radical left” and “dirty” Democrat-run cities. “The sidewalks are disgusting. The streets are disgusting. They’re just in bad shape,” he said. “The doors going into stores are dirty. Everything’s dirty. It smells. It smells of marijuana and other things worse than marijuana.” |
| Oct 9, 2026 |
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
EDMONTON, AB, Oct. 8, 2026 /CNW/ -- Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB), the leading Canadian-based global medical cannabis company, today announced the completion of a major expansion of its facility in Leuna, Germany. The expansion project establishes the Leuna facility as a manufacturing site of excellence, incorporating proven cultivation and post-harvest practices from Aurora's Canadian operations alongside the company's proprietary genetics and product catalogue. The expanded facility has increased cultivation capacity while improving product quality, consistency and operational efficiency, strengthening the facility's role in serving Aurora's growth in Europe. |
| Oct 9, 2026 |
How Many Cannabis Social Clubs Are There In Chile?
In 2005, lawmakers in Chile adopted Law 20.000, which is the basis for the nation’s current approach to cannabis enforcement. The law does provide some level of protection for personal cannabis activity, but is not considered to be adult-use legalization. Medical cannabis has been legal in Chile since 2015. |
| Oct 9, 2026 |
Legacy medical cannabis cultivator Bedrocan declared bankrupt in Netherlands
The Netherlands will shift to international cannabis imports for its domestic MMJ supply after a Dutch court declared Bedrocan, the country’s sole licensed cultivator and one of the oldest medical cannabis companies in the world, bankrupt on Thursday. Bedrocan’s ongoing woes follow the termination on Jan. 1 of its contract with the state health ministry, the company’s biggest client, to supply domestic medical cannabis patients, as Dutch News reported. |
| Oct 9, 2026 |
Federal marijuana rescheduling means institutional capital is coming to cannabis investing The U.S. cannabis industry has spent years waiting for a single catalyst from the federal government to change its trajectory. Investors have watched for banking reform, rescheduling, federal legalization and tax relief as though one event might suddenly erase the barriers that have kept traditional capital on the sidelines. After more than three decades in capital markets, I do not think industries mature that way. Capital tends to move when a series of risks become measurable, familiar and ultimately manageable. |
| Oct 9, 2026 |
The Marijuana Legalization Paradox: More Legal Cannabis, Fewer Teen Users
Most Americans now live in a jurisdiction where cannabis is legal — and use by teens has never been lower. Yes, you read that right. According to the latest findings from the U.S. Centers for Disease Control and Prevention, fewer young people nationwide are using marijuana today than at any time in the last 30 years. |
| Oct 9, 2026 |
NL’s only legal medicinal cannabis grower goes bust
Patients who use medicinal cannabis face having to switch to imported products after the only licensed grower in the Netherlands was declared bankrupt on Thursday. A court in Groningen declared Veendam-based Bedrocan bankrupt two weeks after the company had applied for protection from its creditors. The firm, whose main growing site is in Emmeloord, employs around 70 people. Bedrocan ran into trouble after the health ministry ended its contract at the start of this year. All medicinal cannabis sold in Dutch pharmacies is bought and distributed by the state-run Bureau for Medicinal Cannabis (BMC). |
| Oct 9, 2026 |
More Than A Third Of Hikers Use Marijuana To Enhance Their Experience On The Trail, Poll Shows A significant number of people who hike enhance their experience on the trail with marijuana, according to a new poll. The expedition company Climbing Kilimanjaro surveyed 1,008 U.S. adult hikers, finding that more than a third (35 percent) have hiked while under the influence of cannabis—the most popularly used substance in the poll. |
| Oct 8, 2026 |
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease Quick Read TLRY fell 7% after cannabis revenue shrank while beer drove a 23% revenue record; CGC and ACB each dipped just 1%. MJ and SPY each fell just 0.3%, confirming the selloff targets Tilray Brands specifically rather than the broader cannabis sector. Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Tilray Brands didn't make the cut. Enter your email to see the names that beat TLRY. The report is free. Enter your email and see if any of your stocks made the cut. |
| Oct 8, 2026 |
Europe Now a Growth Priority for North American Cannabis Capital
North American institutional cannabis investors now see the European medical market as a crucial driver of growth, a new survey suggests. ATB Cormark Capital Markets’ latest ‘Capital Markets Cannabis Investor Sentiment Survey’ found that nearly half (47.1%) of US-focused respondents believe multi-state operators (MSOs) should participate in international medical cannabis markets, up from 37.5% in Spring 2026, with the share saying MSOs should not participate collapsing from 37.5% to 11.8%. |
| Oct 8, 2026 |
Shen says he does not support legalizing cannabis in Taiwan
TAIPEI (Taiwan News) — Puma Shen (???), the DPP’s mayoral candidate in Taipei, said in a televised interview Wednesday that he would not push for drug decriminalization and does not support legalizing cannabis in Taiwan. Shen was responding to questions from media personality and politician Jaw Shao-kang (???) about his stance on drug policy, per CNA. Jaw served one term as a Taipei city councilor before being elected to the Legislative Yuan in the 1990s and was the KMT’s vice-presidential nominee in the 2024 election. |
| Oct 8, 2026 |
Tilray posts record revenue but cannabis sales drop, shares fall 4% amid profit pressure
Tilray Brands reported a first-quarter revenue record, rising 23% year-over-year, driven by gains in its beer and distribution segments following the BrewDog acquisition. However, its core cannabis sales declined, falling to $56.1 million, causing investor concern and a 4% drop in its stock price. Despite higher revenue and gross profit, adjusted earnings before interest, taxes, depreciation, and amortization decreased due to factors like global fuel surcharges. The company remains optimistic with a net cash position and reduced debt, but the market will watch closely to see if cannabis sales stabilize and profitability improves in coming quarters. Canopy Growth and Aurora Cannabis, more focused on cannabis, showed smaller stock declines, indicating Tilray's mixed results are company-specific rather than sector-wide. |
| Oct 7, 2026 |
Cannabis Becomes Canada’s Fifth-Most Important Cash Crop
Cannabis has become one of Canada’s most important cash crops since it was first made legal for adult use in 2018. Cannabis legalization transformed the sector from less than 1% of total farm receipts in 2016 to a competitor with crops like soybeans and corn, outpacing durum wheat, barley, lentils, and tobacco. According to Statistics Canada’s annual farm cash receipts data, cannabis farm receipts (Cannabis seeds, vegetative plants, and flowering tops, including leaves) in Canada have grown from $94.8 million in 2016 to more than $3 billion in 2025. |
| Oct 7, 2026 |
Albania Adopts Cannabis Industry Tracking Rules
Albania’s government has adopted new rules for tracking and tracing the cannabis industry. Such rules are commonly referred to as ‘seed-to-sale’ tracking in many legal markets and are standard for emerging cannabis industries around the globe. “The new framework establishes an oversight system covering the entire chain of activity from the import of seeds, seedlings and clones to cultivation, harvesting, drying, processing, storage, transportation and export. It also sets out procedures for the seizure, confiscation and destruction of cannabis-related materials.” reported Albanian Daily News in its local coverage. |
| Oct 7, 2026 |
New Adult-Use Cannabis Retail Restrictions Take Effect In Ohio
New restrictions on the size and potency of adult-use cannabis products took effect this week in Ohio, WCMH reports. The changes could force some businesses to remove products from their shelves. Under the rules enacted by the Division of Cannabis Control (DCC), cannabis flower is now limited to one ounce per package and vape cartridges are limited to three devices per package. Cartridges also now have a THC cap of 90% and cannot exceed two grams. Regulators have also determined that a single serving from a vape product is a two-second inhalation. |
| Oct 7, 2026 |
Dutch Cannabis Patients Facing 10-Month Supply Gap, Many With ‘No Therapeutic Alternative’
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy. Last week, Bedrocan announced that its key Dutch entities had taken emergency financial measures to avoid bankruptcy. The crisis arrives as roughly three-quarters of Bedrocan’s European production capacity falls out of the Dutch patient-supply chain, with no import authorisation granted for Danish-produced material to replace it in the interim. |
| Oct 7, 2026 |
PM says no to cannabis cultivation in Cambodia
Prime Minister Hun Manet has restated his firm opposition to cannabis cultivation in Cambodia, saying the government would not be able to effectively control its production and domestic use. The premier made his remarks today, while presiding over the University of Health Sciences’ the 80th anniversary celebrations in Phnom Penh. “My position, even before I became prime minister, was to oppose the cultivation of cannabis in Cambodia,” he said. |
| Oct 7, 2026 |
Experts issue medical cannabis warning to millions of Britons
Nearly two million unlicensed cannabis items were prescribed privately in England over the past 12 months according to new figures, prompting a warning over potential risks to patients. England’s patient safety commissioner Professor Henrietta Hughes said that immediate measures are required to safeguard people purchasing medical cannabis on online platforms. |
| Oct 7, 2026 |
How Nextleaf Solutions Ltd. (CN: OILS) Is Balancing Brand Growth Against Margin Pressure in Canadian Cannabis
Nextleaf Solutions Ltd. (CN:OILS) is trying to grow a portfolio of consumer cannabis brands and an export Business while absorbing the pricing compression that continues to weigh on Canada's legal market. Its fiscal 2026 results so far show the tension clearly: a profitable first quarter was followed by two loss-making quarters, as gross Margin narrowed and the company spent on sales infrastructure, a second processing site and export capability. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35